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Abstract
Introduction The aim was to determine the diagnostic
accuracy and additional value of diffusion-weighted imag-
ing for detection of malignant lymph nodes in head and
neck squamous cell carcinoma.
Methods Two hundred nineteen lymph nodes, predomi-
nantly smaller than 10 mm (95.4%), in 16 consecutive
patients were evaluated at 1.5 T. Lymph nodes were
evaluated for maximum short axial diameter, morphological
criteria, and apparent diffusion coefficient (ADC) values
(b=0 and b=1,000 s/mm2). Sensitivity, specificity, positive
and negative predictive values as well as diagnostic odds
ratios (DORs) and areas under the curves (AUCs) of ROC
curves were calculated for the various magnetic resonance
imaging (MRI) criteria individually and in combination.
Histological examination of lymph nodes in the neck
dissection specimen was the gold standard to determine
malignant involvement.
Results The optimal ADC threshold was 1.0×10−3 mm2/s.
Using this cutoff point, sensitivity and specificity were
92.3% and 83.9%, respectively. When used in combination
with size and morphological criteria, ADC value <1.0×
10−3 mm2/s was the strongest predictor of presence of
metastasis (DOR=97.6). A model which added ADC
values to the other MRI criteria performed significantly
better than a model without ADC values: AUC=0.98
versus AUC=0.91 (p=0.036).
Conclusion In this study, with predominantly small lymph
nodes, the ADC criterion is the strongest independent
predictor of presence of metastasis. The use of ADC values
in combination with the other MRI criteria significantly
improves the discrimination between malignant and benign
lymph nodes.
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The presence of cervical lymph node metastases is an
important prognostic factor in patients with head and neck
squamous cell carcinoma (HNSCC) as this significantly
worsens the treatment outcome [1–8]. Radiological imaging
plays an increasingly important role in accurate assessment
of the lymph node status of the neck.
Frequently used criteria for differentiation between
benign and malignant lymph nodes are the presence of
necrosis—mainly seen in larger lymph nodes—and assess-
ment of lymph node morphology such as borders and
internal heterogeneity [9, 10]. Also the introduction of
lymph node specific contrast agents like ultrasmall particles
iron oxide on magnetic resonance imaging (MRI) provides
differentiation between benign and malignant lymph nodes
in the head and neck and results are improving [11–16].
Another commonly used criterion is the maximum short
axial diameter for which several studies have been
undertaken to determine the optimal cutoff size [17, 18].
Small lymph nodes with a maximum short axial diameter
below 10 mm are more challenging for radiologists,
because the mere use of this size criterion will result in
misclassification of malignant lymph nodes as normal on
MRI evaluation. According to the literature, the perfor-
mance of MRI is still poor in the assessment of lymph node
metastases, and this concerns especially the detection of
metastases in small lymph nodes [11].
Diffusion-weighted imaging (DWI) is a noninvasive MRI
technique that provides image contrast dependent on the
molecular motion of water. Any architectural changes in the
proportion of extracellular to intracellular water protons—like
metastases in lymph nodes—will alter the diffusion coeffi-
cient of the tissue. Therefore, DWI provides in characteriza-
tion of different tissues and lesions. Previous reports showed
the utility of DWI in the region of the head and neck for
different pathology [19–26]. In studies focused on nodal
staging, the imaging results were based on series with only
clinical positive necks in which large lymph nodes were
selected for evaluation [27–30]. Studies focusing on mainly
negative necks at clinical examination are scarce. The aim of
this study was to prospectively determine the diagnostic
accuracy and additional value of DWI–MRI to conventional
MRI—using size and morphology criteria—for differentia-
tion between malignant and normal cervical lymph nodes.
Materials and methods
Patients
The local medical ethics committee approved this prospec-
tive study. Between March 2006 and December 2007, a
series of 16 consecutive patients with a HNSCC who were
scheduled for a supraomohyoid neck dissection (SOHND),
selective or radical neck dissection (RND) enrolled in this
study. All patients underwent MR imaging as part of the
routine diagnostic workup; the findings of diffusion-
weighted imaging were not used for clinical decision
making. MR imaging was performed previous to ultraso-
nography with fine needle aspiration cytology of lymph
nodes in the neck.
MR imaging
All examinations were performed at 1.5 T (Gyroscan,
Powertrack 6000, Philips, Best, The Netherlands) using a
Head–Neck coil (Philips, Best, The Netherlands). The
Synergy Head–Neck coil was used for both the conven-
tional and diffusion-weighted MR imaging; the range was
from the base of skull to the level of the clavicles. To
ascertain correlation of the conventional images and DWI,
all sequences were acquired with similar geometry.
The conventional MR protocol consisted of axial fat-
suppressed T2-weighted (TR/TE 1704/80), axial and
coronal T1-weighted (TR/TE 400/12), contrast-enhanced
axial and coronal fat-suppressed T1-weighted (TR/TE 740/
12), and coronal short tau inversion recovery (TR/TE/TI
5868/60/15) sequences. Slice thickness was 3 mm; there
was no interslice gap. The matrix was 272×512 with a field
of view 220 (rectangular field of view (RFOV) 80%).
Diffusion-weighted images were acquired in the axial
plane by using a gradient single-shot echo planar imaging
sequence. The sequence was repeated for two b values b=0
and b=1,000 s/mm2 with the following parameters: TR/TE
5666/70, section thickness was 3 mm according to the
conventional protocol, the matrix was 272×512 with a field
of view 400 (RFOV 80%), there was no interslice gap, and
the number of signal acquisition was 6. A total of 64 slices
were acquired which covered the whole neck area from the
skull base to the clavicles. The total scan time was 4 min
54 s. DWI was performed before the contrast-enhanced T1-
weighted sequences. Apparent diffusion coefficient (ADC)
maps were automatically constructed by the postprocessing
software of the MR system.
Image evaluation
Two radiologists with specific experience in head and neck
imaging (12 and 4 years, respectively) and taking part of
multidisciplinary head and neck oncology conferences in a
referral hospital independently evaluated the conventional
images. Both observers were blinded to each other’s MR
assessments and clinical information.
On the conventional MR images, lymph nodes were
assessed for size and morphological criteria. All lymph
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nodes were determined by position and slice number per
neck level, the maximum short axial diameter was recorded
per lymph node, and lymph nodes were classified as normal
(≤10 mm) or malignant (>10 mm). Furthermore, for each
lymph node, it was predicted whether it was benign or
malignant by using the following morphological criteria
determined on the fat-suppressed T2-weighted images: the
border of the lymph node (smooth, lobulated, spiculated, or
indistinct). Presence of smooth and lobulated borders were
considered as indicative of normal lymph nodes whereas
that of spiculated and indistinct borders of malignant lymph
nodes (Fig. 1). Another criterion was the degree of
homogeneity of the signal intensity; homogeneous signal
intensity was considered as normal whereas heterogeneous
signal intensity was considered as indicative of malignant
lymph nodes.
Diffusion-weighted images were evaluated on the MRI
scanner workstation on which the ADC maps were
constructed automatically by the postprocessing software
of the MR system. In consensus, the two radiologists, who
also assessed the conventional MR images, performed the
evaluation of the diffusion-weighted images. To ascertain a
node-by-node correlation between the conventional images
versus the diffusion-weighted images, all lymph nodes on
the T1-weighted and T2-weighted images were correlated
to the corresponding b1000 images. On these b1000
images, a region of interest (ROI) was drawn manually
around each single lymph node, the ROI was copied to the
ADC map, and the ADC value was automatically calculat-
ed by the postprocessing software of the MR machine. This
was done on all subsequent sections that contained lymph
node parenchyma to ensure that most of the lymph node
was included. The final ADC value of a lymph node was an
average of all values from one single lymph node; this was
expressed as mean ± standard deviation. Figure 2 demon-
strates an example of this postprocessing technique. A
necrotic area in a lymph node, determined as a hyperintense
region on the T2-weighted image with a hypointense region
on the (contrast-enhanced) T1-weighted images, was
excluded from the area of analysis.
Pathological examination
All neck dissections were performed “en bloc”. Immedi-
ately after the resection, the surgeon positioned the neck
dissection specimen on a schematic drawing of the neck in
real proportions and fixed it with needles. The pathologist
manually identified and localized the lymph nodes per neck
level in the specimen. The maximum short axial diameter
of all lymph nodes was recorded. Subsequently, lymph
nodes were fixed, sectioned, and hematoxylin–eosin (HE)
stained and the presence of tumor in each lymph node was
examined microscopically. The results at pathology were
used as the reference standard.
Pathological–radiological correlation
The neck was subdivided according to the six different
levels in agreement with the classification of the American
Joint Committee on Cancer; this classification was used by
the radiologists when viewing the MR images and used by
the pathologist when interpreting the specimen after neck
dissection [31].
The results of the measurements on MRI were compared
with the results of the pathological examination of the neck
dissection specimens. By recording the combination of the
maximum short axial diameter and the exact location of
each lymph node per neck level—related to surrounding
anatomic structures such as blood vessels, muscles, and
salivary glands—it was possible to perform a topographic
correlation for each lymph node between the pathological
examination and the MR images.
Statistical analysis
Interobserver agreement with respect to the evaluation of
the criteria size (maximum short axial diameter), border irreg-
ularity, and homogeneity of signal intensity on T2-weighted
images was expressed by Cohen’s kappa-coefficient (κ). For
each lymph node, the scores on MRI criteria were correlated
with the results of pathologic examination of the neck
dissection specimen. Pathologic results with respect to
presence or absence of lymph node metastasis were used
as standard of reference. Results on MRI criteria were
dichotomized and diagnostic accuracy was evaluated in
terms of sensitivity, specificity, positive predictive value
(PPV), and negative predictive value (NPV).
Furthermore, discriminative ability was expressed by the
diagnostic odds ratio (DOR). The higher the DOR, the
higher the ability of a particular criterion to discriminate
between lymph nodes with and without metastasis. A DOR=
1 indicates that the criterion under study has no diagnostic
value; a DOR>1 indicates that the criterion has ability to
discriminate between lymph nodes with and without
metastasis.
The independent contribution of each criterion under
study was analyzed using multivariate logistic regression
models. In these models, presence or absence of metastasis
Fig. 1 Schematic drawing of the four borders for assessment of
cervical lymph nodes
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according to pathologic examination was the dependent
variable and the dichotomized results on MRI criteria were
entered as independent variables. Diagnostic odds ratios,
which can be derived from these models by exponentiation
of the regression coefficients, indicate to what extent each
criterion in the model can be used as an independent
predictor of the presence of metastasis in a lymph node.
Finally, the added diagnostic value of ADC values to the
other MRI criteria (size, border irregularity, and signal
intensity on T2-weighted images) was analyzed by using
multivariate logistic regression models, which included
different sets of MRI criteria. Model-derived predicted
probabilities were used to construct receiver operating
characteristic (ROC) curves. Areas under the curve (AUCs)
with 95% confidence intervals were used to compare the
diagnostic accuracy of various models. Differences between
the AUCs were tested for statistical significance using the
method described by Hanley and McNeil, which accounts
for the fact that the AUCs are derived from the same
sample of patients. Statistical analyses were performed with
SPSS 13 and STATA. In all analyses, p values <0.05 were
considered as indicator for statistical significance [32].
Results
In 16 patients (mean age 59 years [range 40–77 years];
seven women and nine men), a total of 17 neck
dissections were performed: SOHND, n=4; RND, n=4;
and selective neck dissection, n=9. Distribution of the total
of 58 dissected neck levels was as follows: level I, n=17;
level II, n=17; level III, n=12; level IV, n=5; and level V,
n=7. Relevant patient characteristics, clinical findings,
tumor–node–metastasis (TNM) classification and details
of the performed neck dissections are summarized in
Table 1.
At assessment of the MR images of the 58 dissected
neck levels, a total of 281 lymph nodes were detected. Of
these lymph nodes, 62 had a short axial diameter of ≤2 mm.
Because these lymph nodes were not detected at the
pathological examination, they were excluded from further
analysis. The large majority (13 out of 16) of patients
presented without palpable lymph nodes at clinical exam-
ination (clinical negative neck); only a few lymph nodes
exceeded the maximum short axial diameter of 10 mm at
pathological and radiological examination.
Fig. 2 Overview of measure-
ment of the apparent diffusion
coefficient value of cervical
lymph nodes. Axial T1-weight-
ed (a) and fat-suppressed T2-
weighted (b) images are used to
ascertain matching between
lymph nodes (arrows) on the
conventional and the diffusion-
weighted imaging. Two small
lymph nodes (arrows) can also
be observed on the DWI b1000
image (c); on this image regions
of interest are drawn around the
lymph nodes and automatically
copied to the ADC map (d) on
which reference numbers are
correlated to the ADC values
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Pathological examination revealed 219 lymph nodes,
which were matched to the lymph nodes on the MR images.
Most lymph nodes were situated at level I (n=45), level II
(n=100), or level III (n=49). Only 25 nodes were detected
at level IV (n=7) or level V (n=18). Evidence of metastases
was demonstrated in 26 lymph nodes (node-based preva-
lence=11.8%) and in 11 of 16 patients (patient-based
prevalence=68.8%). Lymph node size in relation to the
presence of metastases (n=26) was as follows: 5 mm, n=5;
6 mm, n=4; 7 mm, n=3; 8 mm, n=6; 9 mm, n=1; 10 mm,
n=3; 15 mm, n=1; 18 mm, n=1; 20 mm, n=1; and 30 mm,
n=1. The majority (95.4%) of lymph nodes on MRI
showed a maximum short axial diameter ≤10 mm. Only
ten nodes (4.6%) were >10 mm. Of these ten pathological
determined lymph nodes, six were negative at pathological
examination (range 11–12 mm in maximum short axial
diameter). Four lymph nodes, with maximum short axial
diameter ranging from 15–30 mm, showed massive metasta-
sis. Twenty-two of the 26 metastases were found in the lymph
nodes ≤10 mm. Figure 3 illustrates a lymph node with
maximum short axial diameter of 12 mm with an ADC value
of 1.3×10−3 mm2/s; pathological examination revealed no
metastasis. Observer agreement for the three morphological
criteria was κ=0.86 for size, κ=1.00 for border irregularity,
and κ=0.91 for signal intensity on the T2-weighted images.
Table 2 presents combinations of sensitivity and speci-
ficity that were found using different cutoff values for
ADC. Lower ADC values correspond with higher proba-
bility of lymph node metastasis. ADC values of malignant
lymph nodes were significantly lower compared with
benign lymph nodes with mean (standard deviation, SD)
values of 0.85×10−3 mm2/s (SD 0.19×10−3 mm2/s), and
1.2×10−3 mm2/s (SD 0.24×10−3 mm2/s), respectively. High
sensitivity combined with acceptable specificity was found
for a cutoff point of <1.0×10 versus >1.0×10−3 mm2/s.
This cutoff value was used for further analyses.
Table 3 shows the sensitivity, specificity, PPV and NPV
for dichotomized ADC values, and the other MRI criteria
such as size, border irregularity, and signal intensity on T2-
weighted images. Both the dichotomized size and ADC
criteria are associated with the highest sensitivity, but the
high sensitivity for size is compromised by a high
proportion of false positive results.
Table 4 shows diagnostic odds ratios with 95% confidence
intervals (CI) for the individual MRI criteria when they are
used separately (derived from univariate analyses) and for the
individual MRI criteria when they are used in combination
with each other (derived from multivariate analyses). When
used separately, the border criterion is associated with the
highest ability to discriminate between malignant and benign
lymph nodes (DOR=90.1). However, when used in combi-
nation, the ADC criterion is the strongest independent
predictor of presence of metastasis (DOR=97.6) followed
by the border criterion (DOR=56.0). When evaluated in
combination with the other criteria, the DOR of 4.4 (with 95%
CI 0.7–28.0) associated with size no longer differs signifi-
cantly from 1 and thus has no independent predictive value.
Table 5 presents areas under the curve with 95% con-
fidence intervals from various models. Model 3, adding ADC
values to the other MRI criteria (size, border irregularity, and
Table 1 Clinical findings in 16 consecutive patients with primary head and neck squamous cell carcinoma, clinical TNM classification, and
details of the performed neck dissections.
Patient no. Age (years) Gender Clinical presentation Clinical TNM Neck dissection Dissected levels
Primary tumor location Side Type Side
1 64 M Tongue R T2N0M0 Selective ND R I–III, V
2 75 M Nasopharynx L T2N1M0 Radical ND L I–V
3 53 M Tongue R T3N1M0 Radical ND R I–V
4 62 F Tongue L T3N0M0 Selective ND L I, II
5 58 M Vallecula R T1N0M0 Selective ND R I, II, III, V
6 40 M Tongue L T2N0M0 Selective ND L I–III
7 54 M Nasopharynx L T1N1M0 Selective ND L I–III
8 63 M Retro molar trigonum L T2N0M0 Selective ND L I–IV
9 55 F Submandibular gland L T2N0M0 Selective ND L I, II
10 72 M Tongue L T2N0M0 Supraomohyoid ND L I–III
11 74 F Cheek L T2N0M0 Selective ND L I, II
12 51 F Floor of mouth R T2N0M0 Radical ND R I–V
13 52 F Soft palate L T2N0M0 Radical ND L I–V
14 47 F Tongue R T3N0M0 Supraomohyoid ND R I–III
15 50 F Tongue R T2N0M0 Selective ND R I, II
16 77 M Nose – T2-3N0M0 Supraomohyoid ND R I–III
Supraomohyoid ND L I–III
ND neck dissection, L left, R right, M male, F female
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signal intensity on T2-weighted images), performs signifi-
cantly better thanmodel 2 that does not add ADC values to the
other three criteria: AUC=0.98 versus AUC=0.91 (p=0.036).
Moreover, model 1, which includes only ADC as predictor
of presence of metastasis, performs nearly as well as model
2, which includes the other three MRI criteria as predictors:
AUC=0.89 versus AUC=0.91 ( p=0.52).
Discussion
The results show that apparent diffusion coefficient values
calculated on the diffusion-weighted images, alone or in
combination with other morphological criteria, are useful in
discriminating malignant from benign lymph nodes in head
and neck squamous cell carcinoma. ADC values of
Table 2 Sensitivity, specificity, and diagnostic odds ratio with 95% confidence interval for the diagnosis of malignant cervical lymph nodes for
different threshold values of the apparent diffusion coefficient.
Threshold Sensitivity (%) Specificity (%) DOR (95% CI)
<0.9×10 versus >0.9×10−3 mm2/s 69.2 92.2 26.7 (10.0–71.5)
<0.94×10 versus >0.94×10−3 mm2/s 84.6 90.2 50.4 (15.7–161.6)
<1.0×10 versus >1.0×10−3 mm2/s 92.3 83.9 62.7 (14.1–279)
Fig. 3 Fifty-one-year-old pa-
tient with a squamous cell car-
cinoma in the floor of the mouth
on the left side (arrowheads).
The axial T1-weighted (a) and
fat-suppressed T2-weighted (b)
images show in level II on the
left side an enlarged lymph node
(arrow) with a maximum short
axial diameter of 12 mm. This
lymph nodes is easily recog-
nized on the diffusion-weighted
image at b1000 (c). The
corresponding area on the ap-
parent diffusion coefficient map
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malignant lymph nodes were significantly lower compared
to benign lymph nodes.
At present, there are only few reports that demonstrate
the usefulness of DWI–MRI in characterizing lymph nodes
in the neck. Some studies reported the ability of DWI to
discriminate between different histological lymph node
cancers in the neck [28–30]. Others showed that ADC
determination on DWI–MRI may have added value in
discriminating malignant from benign lymph nodes in the
neck [19, 20, 27]. All studies were performed in patients
with palpable cervical lymphadenopathy (clinical positive
necks), and further evaluation by MRI was limited to
selected enlarged lymph nodes.
In contrast to previous reports, this study is unique in
that it mainly dealt with patients with clinically negative
necks. In only three out of 16 patients lymph nodes were
palpable at clinical examination; however, in only two
patients an enlarged lymph node with maximum short axial
diameter ranging from 18 to 30 mm could also be
demonstrated on MRI and at pathological examination.
The large majority of lymph nodes (95.4%) on MRI were
≤10 mm; within this group, the pathologically confirmed
malignant lymph nodes ranged a maximum short axial
diameter of 5–10 mm. Those small lymph nodes would all
be assigned as benign based on the size criterion. Especially
the multivariate regression analyses demonstrate that the
size criterion no longer differs significantly malignant from
benign lymph nodes and thus has no independent predictive
value. When used separately, the border criterion is
associated with the highest ability to discriminate between
lymph nodes with and without metastasis; however, when
used in combination, the ADC criterion is the strongest
independent predictor of presence of metastasis followed by
the border criterion (Table 4).
These results in the clinically negative necks are of great
clinical relevance as DWI shows to be an accurate tool to
differentiate metastases in small lymph nodes. In a
radiologically negative neck, the planned neck dissection
could be converted to a wait-and-scan policy, whereas the
radiologically determined positive neck would support the
decision to perform a neck dissection. The relative high
sensitivity and NPV for the size criterion in this study only
accounts for lymph nodes exceeding 10 mm in maximum
short axial diameter (Table 3). However, as in this study, the
large majority of lymph nodes were ≤10 mm; the size
criterion does no longer differ in these lymph nodes
between malignant and benign lymph nodes. This is
expressed by the low DOR for the size criterion in the
univariate and multivariate logistic regression analyses
(Table 4).
The optimal ADC threshold for this study population
appeared to be 1.0×10−3 mm2/s (Fig. 4); when the criteria
size and morphology on the conventional MR protocol
were combined with this ADC threshold value, the area
Table 4 Diagnostic odds ratios with 95% confidence intervals for apparent diffusion coefficient levels and three assessed morphological criteria
(size, border, and signal intensity).




ADC threshold (<1.0×10 versus >1.0×10−3 mm2/s) 62.7 (10.0–71.5) 97.6 (9.7–982)
Size (≤10 versus >10 mm) 18.5 (4.2–80.4) 4.4 (0.7–28.0)
Border irregularity (spiculated/indistinct versus smooth/lobulated) 90.1 (22.5–361) 56.0 (4.4–719)
Signal intensity on T2-weighted image (heterogeneous versus homogeneous) 18.2 (6.7–49.4) 12.8 (1.8–91.6)
Results are derived from univariate and multivariate logistic regression analyses
DOR Diagnostic odds ratio, ADC apparent diffusion coefficient
Table 3 Sensitivity, specificity, positive predictive value, and negative predictive value for the diagnosis of malignant lymph nodes for the
MR criteria: apparent diffusion coefficient (≤1.0×10 versus >1.0×10−3 mm2/s), size (maximum short axial diameter ≤10 versus >10 mm),
border irregularity and signal intensity on T2-weighted images.
Criterion Sensitivity (%) Specificity (%) PPV (%) NPV (%)
ADC (<1.0×10 versus >1.0×10−3 mm2/s) 92.3 83.9 43.6 98.8
Size (≤10 versus >10 mm) 92.3 60.6 24.0 98.3
Border irregularity on T2-weighted images (spiculated/indistinct
versus smooth/lobulated)
61.5 98.3 84.2 94.4
SI on T2-weighted images (heterogeneous versus homogeneous) 50.0 94.8 56.5 93.3
PPV positive predictive value, NPV negative predictive value, ADC apparent diffusion coefficient, SI signal intensity
3 Sens tivity, specificity, positive predictive v lue, and
negative predictive value for the d agnosis of malignant lymph
n des for the MR criteria: apparent diffusion coefficient (≤1.0×10
v rsus >1.0×10−3 mm2/s), size (maximum short axial diameter ≤10
versus >10 mm), border irregularity nd signal intensity on T2-
weighted images.
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under the curve significantly increased. Figure 5 illustrates
the ROC curves derived from predicted probabilities from
models including different criteria sets. A model which
added ADC values to the other MRI criteria performed
significantly better than a model without ADC values
whereas the model which includes only ADC performs
nearly as well as the model which includes the other three
MRI criteria. In a previous study, the same assessed
morphological criteria showed—in addition to the size
criterion—an increased AUC from 0.91 to 0.96. However,
this accounted solely for the experienced head and neck
radiologist in a series with higher prevalence of metastases
(27.2%) and larger assessed lymph nodes (18%>10 mm)
[33].
The chosen ADC threshold of 1.0×10−3 mm2/s in this
study might be difficult to reproduce in other centers. This
is probably based on the differences in study design and
techniques that will be used and differences in selection of
patient series, i.e., the sizes of assessed lymph nodes might
influence the choice of the ADC threshold as larger lymph
nodes tend to show necrosis and this will affect the ADC
values. To use DWI for characterizing lymph nodes in
general practice, there should be a well-established thresh-
old for the ADC values. It is advisable that thresholds are
reproducible in different centers and on different MR
machines, to set the ADC threshold to the proper value
depends on the differential diagnosis of expected lymph
node pathology.
Some limitations of this study have to be addressed.
Firstly, the low prevalence of malignant lymph nodes, with
as a result that the negative predictive values were high for
all MRI criteria. It must be kept in mind that predictive
values are not independent of the setting in which the test is
used and are strongly influenced by the prevalence;
metastases were present in only 26 out of 219 lymph nodes
Fig. 4 Graph of box plots shows the apparent diffusion coefficient
(ADC) values of malignant and benign lymph nodes. The horizontal
line in the box represents the median (50th percentile), whereas the top
and the bottom represent the 25th and 75th percentile, respectively.
The whiskers represent the range from the largest and the smallest
measured ADC data. The ADC values of benign lymph nodes are
higher than compared than those of malignant lymph nodes
Fig. 5 Receiver operating characteristics curves derived from pre-
dicted probabilities from models including different sets of MRI. A
model which added ADC values to the other MRI criteria (green line)
performed significantly better than a model without ADC values (gray
line): AUC=0.98 versus AUC=0.91 ( p=0.036). Moreover, the model
which includes only ADC (blue line) as predictor of presence of
metastasis performs nearly as well as the model, which includes the
other three MRI criteria as predictors: AUC=0.89 versus AUC=0.91
( p=0.52)
Table 5 Area under the curve and 95% confidence intervals for predicted probabilities of malignant lymph nodes derived from four models
which included different combinations of MRI criteria.
Model Criteria AUC 95% CI
1 ADC (alone) 0.89 0.86–0.92
2 Size, border, and signal intensity on T2-weighted images 0.91 0.84–0.99
3 ADC, size, border, and signal intensity on T2-weighted images 0.98 0.97–1.00
4 Size and ADC 0.94 0.91–0.96
AUC area under the curve, ADC apparent diffusion coefficient
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and negative predictive values of tests tend to be high when
applied in a population with a low likelihood of the disease.
It also has to be mentioned that the primary tumor sites in
this study, which are relatively more likely to show small
metastases, have been of influence especially on the size
criterion showing low diagnostic accuracy and additional
value. Secondly, in nine out of 45 lymph nodes (20%) with a
size of 3–4 mm in maximum short axial diameter, ADC
values were observed below the threshold of 1.0×10−3 mm2/s.
None of these small lymph nodes showed histopathological
evidence of metastasis; partial volume effect when drawing
ROIs on the b1000 images around these small lymph nodes
might be responsible for the false positive results. Thirdly,
although the scan time of DWI will only take less than
5 min, it must be said that evaluating all lymph nodes at the
MR workstation is time consuming.
Conclusions
We demonstrated in a series with predominantly small lymph
nodes that ADC values calculated on the diffusion-weighted
MRI is a strong predictor of the presence of metastasis,
independently from other predictor such as size and
morphology, in patients with head and neck squamous cell
carcinoma (HNSCC). The use of ADC values in combina-
tion with the other MRI criteria significantly improves the
discrimination between malignant and benign lymph nodes.
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